News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - MedTech & Diagnostics
Proposed investor test threatens to cripple medtech innovation, warns MTAA
MedTech News: The Medical Technology Association of Australia (MTAA) has voiced concerns during a public hearing of the Parliamentary Joint […]
MoreNews & Trends - Biotechnology
GSK-acquired Australian cancer drug earns Prime Minister’s Prize for Innovation
Biotech News: Professors Andrew Wilks and Dr Chris Burns have been awarded the prestigious $250,000 Prime Minister’s Prize for Innovation, […]
MoreDigital & Innovation
Embedding customer experience (CX) at the heart of your organisation: AbbVie’s Head of Strategy and Innovation
In this podcast, Mahesh Malalage, Head of Strategy and Innovation at AbbVie ANZ, unveiled insights into the pivotal role of […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
MoreESG
Bayer launches nation’s first interactive garden, shaped as the female reproductive system
Social Impact: Bayer has unveiled a unique initiative aimed at prioritising women’s health: Australia’s first Lady Garden, located in Toowoomba’s […]
MoreHuman Resources
Medtronic and AbbVie claim top spot in Great Place To Work ANZ awards
People & Culture: Great Place To Work ANZ has unveiled its 2024 list of the Best Workplaces, marking a significant […]
MoreMedical and Science
Aussie researchers secure funding for world-first cardioprotective drug
Medical & Science: The Australian government is investing nearly $18 million from the Medical Research Future Fund (MRFF) into a […]
MoreCommunication
Australians’ trust in mainstream health media is in crisis
Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Government inaction on mental illness faces overwhelming criticism ahead of federal election
October 11, 2024
in News & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
October 11, 2024
in News & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
October 11, 2024
in News & Trends - Pharmaceuticals
J&J MedTech appoints new ANZ leader
October 10, 2024
in Leadership & Management
GSK-acquired Australian cancer drug earns Prime Minister’s Prize for Innovation
October 10, 2024
in News & Trends - Biotechnology
Proposed investor test threatens to cripple medtech innovation, warns MTAA
October 10, 2024
in News & Trends - MedTech & Diagnostics
Stark picture of Australia’s cardiovascular risk revealed amid $6 billion health division growth
October 10, 2024
in News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
October 8, 2024
in News & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
October 8, 2024
in News & Trends - Pharmaceuticals
Abbott showcases leadless pacemaker system to local stakeholders
October 8, 2024
in News & Trends - MedTech & Diagnostics
Australian scientists pivotal in new drug class from BMS
October 8, 2024
in News & Trends - Pharmaceuticals
LifeHealthcare reveals next-gen Verisus robotic system
October 8, 2024
in News & Trends - MedTech & Diagnostics
First PBS-listed drug to reduce cardiovascular risk in high triglyceride patients
October 8, 2024
in News & Trends - Pharmaceuticals
GSK report reveals $3.50 economic return for every dollar invested on vaccines
October 8, 2024
in News & Trends - Pharmaceuticals
Aussie researchers secure funding for world-first cardioprotective drug
October 8, 2024
in Medical and Science
APAC medtech company scores TGA approval in heart disease
October 4, 2024
in News & Trends - MedTech & Diagnostics
New state-based pilot to back home-grown medtech innovation
October 4, 2024
in News & Trends - MedTech & Diagnostics
Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis
October 4, 2024
in News & Trends - Pharmaceuticals
Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives
October 4, 2024
in News & Trends - Pharmaceuticals
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More